Perioperative Gemcitabine + Erlotinib Plus Pancreaticoduodenectomy for Resectable Pancreatic Adenocarcinoma: ACOSOG Z5041 (Alliance) Phase II Trial
Titel:
Perioperative Gemcitabine + Erlotinib Plus Pancreaticoduodenectomy for Resectable Pancreatic Adenocarcinoma: ACOSOG Z5041 (Alliance) Phase II Trial
Auteur:
Wei, Alice C. Ou, Fang-Shu Shi, Qian Carrero, Xiomara O’Reilly, Eileen M. Meyerhardt, Jeffrey Wolff, Robert A. Kindler, Hedy L. Evans, Douglas B. Deshpande, Vikram Misdraji, Joseph Tamm, Eric Sahani, Dushyant Moore, Malcolm Newman, Elliot Merchant, Nipun Berlin, Jordan Goff, Laura W. Pisters, Peter Posner, Mitchell C.